# An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System

> **NCT04210622** · — · COMPLETED · sponsor: **Medtronic Cardiac Ablation Solutions** · enrollment: 16 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DEVICE:** Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System

## Key facts

- **NCT ID:** NCT04210622
- **Lead sponsor:** Medtronic Cardiac Ablation Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-07-04
- **Final completion:** 2020-06-18
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04210622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04210622, "An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04210622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*